A detailed history of Larson Financial Group LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Larson Financial Group LLC holds 147 shares of BNTX stock, worth $15,014. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147
Previous 135 8.89%
Holding current value
$15,014
Previous $10,000 70.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$78.36 - $124.66 $940 - $1,495
12 Added 8.89%
147 $17,000
Q2 2024

Aug 02, 2024

BUY
$80.36 - $102.87 $8,036 - $10,287
100 Added 285.71%
135 $10,000
Q1 2024

May 03, 2024

BUY
$88.96 - $112.35 $3,113 - $3,932
35 New
35 $3,000
Q1 2022

May 05, 2022

SELL
$126.25 - $231.85 $505 - $927
-4 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$216.64 - $362.52 $866 - $1,450
4 New
4 $1,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.